奥扎格雷联合依达拉奉治疗急性脑梗死的疗效观察 |
| |
引用本文: | 田玲玲. 奥扎格雷联合依达拉奉治疗急性脑梗死的疗效观察[J]. 中国临床实用医学, 2007, 3(1): 44-45. DOI: 10.3760/cma.j.issn 1673-8799.2009.07.24 |
| |
作者姓名: | 田玲玲 |
| |
作者单位: | 聊城市二院,252600; |
| |
摘 要: | 目的 探讨奥扎格雷联合依达拉奉在急性脑梗死(ACI)患者中的应用疗效.方法 120例急性脑梗死患者随机分为:治疗组:奥扎格雷联合依达拉奉治疗40例,对照组:单用奥扎格雷(A组)40例,单用依达拉奉(B组)40例,分别测治疗0,7,14 d的CRP,D-二聚体,并进行神经功能缺损和日常生活能力指数(BI)评分.结果 两组患者基础病情无明显差异情况下,治疗后血浆CRP和D-二聚体含量均较治疗前明显下降,神经功能缺损评分明最好转,差异有统计学意义(P<0.01);但A、B两组间比较无明显差异(P>0.05),治疗组和对照组比较差异有统计学意义(P<0.05).结论奥扎格雷联合依达拉奉治疗急性脑梗死,较单独应用治疗效果明显.
|
关 键 词: | 奥扎格雷 依达拉奉 急性脑梗塞 |
The therapeutic observation of Edaravone combined with Ozagrel in treatment for Acute Cerebral In-farction |
| |
Abstract: | Objective To investigate the therapeutic of Edaravone combined with Ozagrel in treatment for Acute Cerebral Infarction. Methods A total of 120 patients acute ischemic cerebral infarction were random-ly divided into therapy group which treated with Edaravone combined with Ozagrel and control group which trea-ted with Ozagrel solo(group A) and treated with Edaravone solo( group B) ,the C-reactive protein(CRP) and D-dimmer were measured at 0 st day,7 st day,and 14 st day,the uncontrol of nervus and Barthel index(BI)were marked. Results The two groups patients had no difference in conditions,, It has marked difference in C-reac-tive protein(CRP), D-dimmer, the uncontrol of nervus after treatment, (P<0.01) ,but no difference in group A and group B (P>0.05). The therapy group and control group has marked difference. (P<0.05). Conclusion The therapeutic of Edaravone combined with Ozagrcl in treatment for Acute Cerebral Infarction was batter than treated solo. |
| |
Keywords: | OzagrelEdaravoneAcute Cerebral InfarctionTherapeutic |
|
|